Amneal Pharmaceuticals (AMRX) EBITDA (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly EBITDA of $141.8 million for Q1 2026, up 41.28% year-over-year from $100.3 million in Q1 2025, and up 26.54% quarter-over-quarter from $112.0 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) EBITDA (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' EBITDA history runs 10 years deep, the most recent figure standing at $141.8 million for Q1 2026.
- In Q1 2026, EBITDA rose 41.28% year-over-year to $141.8 million; the TTM figure through Mar 2026 stood at $435.5 million (up 20.84% YoY), while the FY2025 annual figure was $394.1 million, up 58.06% from the prior year.
- EBITDA for Q1 2026 stood at $141.8 million, up from $112.0 million in the prior quarter.
- The five-year high for EBITDA was $141.8 million in Q1 2026, with the low at -$198.6 million in Q2 2022.
- The 5-year median for EBITDA is $75.8 million (2024), against an average of $57.3 million.
- The sharpest annual moves came in 2022 and 2023: EBITDA sank 395.92% in 2022, then surged 34349.0% in 2023.
- Amneal Pharmaceuticals' EBITDA stood at $138.1 million in 2022, then plunged by 89.72% to $14.2 million in 2023, then soared by 434.02% to $75.8 million in 2024, then soared by 47.81% to $112.0 million in 2025, then grew by 26.54% to $141.8 million in 2026.
- Business Quant data shows AMRX's EBITDA at $141.8 million in Q1 2026, $112.0 million in Q4 2025, and $70.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.85 Bn | 39.19 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.40 Bn | 29.73 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.42 Bn | 15.03 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.69 Bn | 5.57 Bn | 334.51 Mn | 129.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 129.77 Mn |
| Mar 31, 2026 | 141.77 Mn |
| Dec 31, 2025 | 112.03 Mn |
| Sep 30, 2025 | 70.34 Mn |
| Jun 30, 2025 | 111.37 Mn |
| Mar 31, 2025 | 100.35 Mn |
| Dec 31, 2024 | 75.79 Mn |
| Sep 30, 2024 | 88.81 Mn |
| Jun 30, 2024 | 95.47 Mn |
| Mar 31, 2024 | -10.75 Mn |
| Dec 31, 2023 | 14.19 Mn |
| Sep 30, 2023 | 75.65 Mn |
| Jun 30, 2023 | 80.08 Mn |
| Mar 31, 2023 | 34.45 Mn |
| Dec 31, 2022 | 138.06 Mn |
| Sep 30, 2022 | 44.35 Mn |
| Jun 30, 2022 | -198.62 Mn |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 11.18 Mn |
| Sep 30, 2021 | 28.52 Mn |